ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,691,459 | +102.6% | 308,548 | +60.6% | 0.31% | +110.3% |
| Q2 2023 | $74,872,979 | +6.9% | 192,115 | +2.2% | 0.15% | -2.0% |
| Q1 2023 | $70,020,450 | +41.5% | 187,934 | +43.8% | 0.15% | +34.2% |
| Q4 2022 | $49,497,929 | +38.5% | 130,660 | +29.1% | 0.11% | +42.3% |
| Q3 2022 | $35,741,000 | +6518.7% | 101,232 | +6473.5% | 0.08% | +7700.0% |
| Q4 2021 | $540,000 | -84.1% | 1,540 | -86.3% | 0.00% | -92.9% |
| Q3 2021 | $3,396,000 | +8390.0% | 11,245 | +3085.6% | 0.01% | – |
| Q3 2019 | $40,000 | -83.5% | 353 | -81.9% | 0.00% | -100.0% |
| Q1 2019 | $242,000 | -78.7% | 1,946 | -87.0% | 0.00% | -80.0% |
| Q3 2018 | $1,134,000 | – | 14,954 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |